A detailed history of Keudell transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keudell holds 16,452 shares of BMY stock, worth $652,486. This represents 0.27% of its overall portfolio holdings.

Number of Shares
16,452
Previous 10,941 50.37%
Holding current value
$652,486
Previous $561,000 59.0%
% of portfolio
0.27%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $264,417 - $299,798
5,511 Added 50.37%
16,452 $892,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $12,216 - $14,578
252 Added 2.36%
10,941 $561,000
Q3 2023

Oct 18, 2023

SELL
$57.89 - $64.73 $49,785 - $55,667
-860 Reduced 7.45%
10,689 $620,000
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $2,930 - $3,254
-46 Reduced 0.4%
11,549 $738,000
Q1 2023

Apr 18, 2023

SELL
$65.71 - $74.53 $34,957 - $39,649
-532 Reduced 4.39%
11,595 $803,000
Q4 2022

Jan 20, 2023

SELL
$68.48 - $81.09 $139,562 - $165,261
-2,038 Reduced 14.39%
12,127 $0
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $345 - $204,471
-2,661 Reduced 15.81%
14,165 $1.01 Million
Q2 2022

Jul 18, 2022

SELL
$72.62 - $79.98 $151,703 - $167,078
-2,089 Reduced 11.04%
16,826 $1.3 Million
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $85,149 - $102,102
1,385 Added 7.9%
18,915 $1.38 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $221,545 - $258,270
4,131 Added 30.83%
17,530 $1.09 Million
Q3 2021

Oct 20, 2021

SELL
$59.17 - $69.31 $47,395 - $55,517
-801 Reduced 5.64%
13,399 $793,000
Q2 2021

Jul 13, 2021

SELL
$61.91 - $67.42 $5,509 - $6,000
-89 Reduced 0.62%
14,200 $949,000
Q1 2021

Apr 13, 2021

SELL
$59.34 - $66.74 $24,388 - $27,430
-411 Reduced 2.8%
14,289 $902,000
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $124,314 - $140,870
-2,153 Reduced 12.78%
14,700 $912,000
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $65,987 - $73,122
-1,149 Reduced 6.38%
16,853 $1.02 Million
Q2 2020

Jul 14, 2020

BUY
$54.82 - $64.09 $68,908 - $80,561
1,257 Added 7.51%
18,002 $1.06 Million
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $20,648 - $30,006
-445 Reduced 2.59%
16,745 $933,000
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $291,520 - $380,261
5,924 Added 52.58%
17,190 $1.1 Million
Q2 2019

Aug 23, 2019

BUY
$44.62 - $49.34 $502,688 - $555,864
11,266 New
11,266 $521,000
Q2 2019

Aug 21, 2019

SELL
$44.62 - $49.34 $500,904 - $553,890
-11,226 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$45.12 - $53.8 $506,517 - $603,958
11,226 New
11,226 $536,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.